SEQSTER Announces Expanded Partnership with Praxis Precision Medicines to Accelerate Clinical Trials in CNS Disorders

“SEQSTER has been a foundational element of our clinical trial ...

SEQSTER Announces Expanded Partnership with Praxis Precision Medicines to Accelerate Clinical Trials in CNS Disorders2026-02-02T05:27:31-08:00

SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences for a Second Consecutive Year

"Receiving this recognition for the second year in ...

SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences for a Second Consecutive Year2024-10-08T07:22:36-07:00

SEQSTER and PatientsLikeMe Announce Strategic Partnership to Power Connected Patient Health Hub with Real-Time EHR Data

"Partnering with SEQSTER empowers us to realize the full ...

SEQSTER and PatientsLikeMe Announce Strategic Partnership to Power Connected Patient Health Hub with Real-Time EHR Data2024-09-05T05:20:25-07:00

Boston University Announces Launch of SEQSTER’s 1-Click Records™ to Aid in Development of Early Alzheimer’s Screening Tool

“Early intervention is crucial in managing Alzheimer's, and ...

Boston University Announces Launch of SEQSTER’s 1-Click Records™ to Aid in Development of Early Alzheimer’s Screening Tool2024-07-29T07:06:22-07:00

Antidote Partners with SEQSTER to Accelerate Patient Identification & Enrollment for Clinical Trials

“Our mission at Antidote has always been to ...

Antidote Partners with SEQSTER to Accelerate Patient Identification & Enrollment for Clinical Trials2024-07-08T05:00:05-07:00

The Multiple Sclerosis Association of America (MSAA) Selects SEQSTER to Accelerate Patient-Centricity & Innovation

"I am deeply honored and profoundly excited to ...

The Multiple Sclerosis Association of America (MSAA) Selects SEQSTER to Accelerate Patient-Centricity & Innovation2024-03-21T04:14:12-07:00
Go to Top